Clicky

Enanta Pharmaceuticals, Inc.(ENTA) News

Date Title
May 27 Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 22 Enanta Pharmaceuticals Announces Data from its Phase 2 Study of Zelicapavir in Children with Respiratory Syncytial Virus to be Presented at the 43rd Annual ESPID Meeting
May 15 Does Enanta Pharmaceuticals (ENTA) Have the Potential to Rally 189.58% as Wall Street Analysts Expect?
May 15 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 12 Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates
May 12 Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
May 12 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2025
Apr 8 Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
Mar 12 Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium
Feb 15 With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns
Feb 15 President of Enanta Pharmaceuticals Picks Up 5.9% More Stock
Feb 14 Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade
Feb 10 Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
Feb 10 Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
Feb 10 Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024
Oct 2 Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?
Sep 27 J&J builds case for Talvey; FDA panel questions PD-1 drugs for certain cancers
Sep 26 Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
Sep 3 Enanta Pharmaceuticals to Participate in Investor Conferences in September
May 29 Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference